Postoperative Pain Market: Overview
One of the main postoperative adverse outcomes is pain that causes prolonged hospital stay, physical distress and increasing incidences of readmissions of patients post surgery. The post operative pain is crucial to manage as single analgesics are not able to provide effective pain relief for moderate or severe pain and are also associated with side effects such as vomiting, nausea, bleeding or sedation. The major focus of postoperative pain treatment is not only to reduce pain intensity but also to improve post operative results and increase patient comfort.
The postoperative pain management is the most integral part of the patient treatment because it provides patient comfort, initiates mobilization, lessens the possibility of cardiac, pulmonary and neuropathic pain complications, reduced risk of thrombosis and low cost of care. The postoperative pain treatment consist mainly multimodal analgesic treatment that includes combination of various analgesics that act by various mechanism of actions. The various classes of drugs used in postoperative pain management are as follows:
- Opioids: morphine, meperidine, fentanyl, hydromorphone
- Non-steroidal anti-inflammatory drugs: paracetamol (acetaminophen), ibuprofen, ketorolac tromethamine
- Cyclooxygenase-2-selective inhibitors: celecoxib, etoricoxib, rofecoxib
- N-methyl-D-aspartate antagonists: ketamine, magnesium
- Alpha-2 adrenergic agonists: clonidine, dexmedetomidine
- Gabapentin-type drugs: pregabalin
- Glucocorticoids: dexamethasone
- Cholinergic drugs: nicotine
- Local anesthetics
Postoperative Pain Market: Trends and Dynamics
According to National Center for Health Statistics, approximately 100 million surgeries are carried out in United States each year. It’s been perceived that at least 50 million procedures require postoperative pain medication. The major concern with prescription painkillers is that opioids or narcotic drugs tend to obtain habit in patients if not monitored by physician may also result in death due to drug overdose. Hence, the opioids are preferred in severe pain and the dose is decreased over the course of treatment withdrawal.
According to the Centre for Disease Control and Prevention (CDC) death due to drug overdose has increased significantly over the last decade, prescription painkiller overdoses killed nearly 15,000 people in the United States in 2008. This is more than 3 times the 4,000 people killed by these drugs in 1999. While in 2010, about 12 million Americans (age 12 or older) reported nonmedical use of prescription painkillers in the past year. Thus, even after constant surveillance of Drug Enforcement Administration (DEA) and other regulatory authorities the prescription painkiller overdoses are increasing hence, most of the drugs used against postoperative pain are preferred to be non-narcotic after discharge of patients.
The major drivers of postoperative pain market is elevating number of geriatric population, increasing prevalence of lifestyle and senile diseases, high patient awareness about various surgeries and operations, increase in accidents and trauma situations and increasing research and development activities to come with safe and effective pain management treatment.
Postoperative Pain Market: Region-wise Outlook
North America was observed to be the leading postoperative pain market because the annual procedures performed in year 2010 are 51.4 million. Thus, the major drivers of postoperative pain in North America are increase in geriatric population, high public awareness about safe surgeries and post operative results and highly regulated market under constant surveillance of various regulatory authorities. Followed by Europe, it was observed to be the second largest market of postoperative pain. Asia-Pacific and Rest of the World were observed to be the growing market for safe and cost effective postoperative treatments as the emerging economies are developing its healthcare infrastructure along with various industry supportive regulatory reforms that might also include growth of this market.
The major market players in postoperative pain market are DURECT Corporation, A.P. Pharma, Inc., Novartis AG, Pfizer Inc., Bayer AG, BTG International Ltd., Grunenthal GmbH and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.